Uniqure N V (QURE) Return on Equity ROE from the first quarter 2026 to first quarter 2025 and annually, average high and low, overall ranking from Mar 31 2026 to Mar 31 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Uniqure N v   (NASDAQ: QURE)

Uniqure N V 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Uniqure N V in the first quarter 2026?
Uniqure N V recorded a cumulative net loss of $-209 million during 12 months ending in the first quarter 2026, resulting in a negative return on equity (ROE) of -145.81%.

Within the Major Pharmaceutical Preparations industry 278 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the fourth quarter 2025 from 3264 to 3590.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Equity Change 343.34 % - 309.78 % - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -209 -199 -235 -199 -218
Return On Equity (TTM) -145.81 % -174.03 % -373.73 % -1010.74 % -483.87 %
QURE's Total Ranking # 3590 # 3264 # 3517 # 3659 # 2867
Equity (TTM) in Millions 149 199 229 -4 34
Seq. Equity Change -24.92 % -13.05 % - - -
Seq. Net Income Change - - - - -

Back to QURE Management Effectiveness >> QURE's 5 Years Annual ROE >> Compare QURE ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 279
Sector # 606
Overall # 3590

Return On Equity Statistics
High Average Low
77.18 %
-119.13 %
-1010.74 %
(Jun 30 2021)   (Jun 30 2025)





QURE Annual Return On Equity (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Equity in Millions 199 -7 208 476 596
Y / Y Equity Change - - -56.37 % -20.1 % 144.27 %
Net Income in Millions -199 -240 -308 -127 330
Y / Y Net Income Change - - - - -
Return On Equity -100.04 % - -148.54 % -26.64 % 55.32 %

Back to QURE Management Effectiveness >> QURE's 5 Years Annual ROE >> Compare QURE ROE to its Competitors




More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
QURE's' Return on Equity at Yahoo Finance
QURE's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for QURE's Competitors
Subscribers only: Roe for Uniqure N V 's Suppliers
Subscribers only: Return On Equity for QURE's Customers




Companies with similar Return On Equity at Mar 31 2026, within Healthcare Sector ROE

Date modified: 2026-09-26T07:30:32+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.